片頭痛治療薬の世界市場 2024-2028Global Migraine Drugs Market 2024-2028 片頭痛治療薬の世界市場 2023-2027 片頭痛治療薬市場は2022-2027年に11億3992万米ドルで成長し、予測期間中のCAGRは6.05%で加速すると予測されます。当レポートでは、片頭痛治療薬市場の全体的な分析、市場規模... もっと見る
日本語のページは自動翻訳を利用し作成しています。
サマリー片頭痛治療薬の世界市場 2023-2027片頭痛治療薬市場は2022-2027年に11億3992万米ドルで成長し、予測期間中のCAGRは6.05%で加速すると予測されます。当レポートでは、片頭痛治療薬市場の全体的な分析、市場規模と予測、動向、成長促進要因、課題に加え、約25のベンダーを網羅したベンダー分析も提供しています。 現在の市場シナリオ、最新動向と促進要因、市場環境全体に関する最新分析を提供しています。片頭痛に悩む患者数の増加、再生医療の登場、臨床効果の高い新クラスの片頭痛治療薬の登場などが市場を牽引しています。 Technavioの片頭痛治療薬市場は以下のように区分される: エンドユーザー別 - 病院 - 小売 - オンライン タイプ別 - 予防 - 予防 地域別 - 北米 - ヨーロッパ - アジア - その他の地域(ROW) 本調査では、片頭痛治療薬の進歩が、今後数年間の片頭痛治療薬市場の成長を促進する主な要因の1つであるとしている。また、片頭痛治療啓発プログラムの増加や薬剤の改良は、市場の大きな需要につながります。 本レポートでは、片頭痛治療薬市場について以下の分野をカバーしています: - 片頭痛治療薬市場のサイジング - 片頭痛治療薬市場予測 - 片頭痛治療薬市場の産業分析 アムニール・ファーマシューティカルズ・インク、アストラゼネカ、ボシュ・ヘルス・インク、バイエルAG、ドクター・レディス・ラボラトリーズ・リミテッド、イーライリリー・アンド・カンパニー、エンド・インターナショナルPlc、グラクソ・スミスクラインPlc、HルンドベックAS、ジョンソン・アンド・ジョンソン・サービス・インク、メルクKGaA、ノイリスInc.、大塚ホールディングスInc.Ltd.、ファイザーInc.、サノフィ、テバ・ファーマシューティカル・インダストリーズLtd.、ウィンストン・ファーマシューティカルズLtd.また、片頭痛薬市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を練り、来るべき成長機会をすべて活用するのに役立つものです。 本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートには、主要ベンダーの分析に加え、包括的な市場およびベンダーランドスケープが含まれています。本レポートの詳細については、https://www.technavio.com/report/migraine-drugs-market-industry-analysis をご覧ください。 当出版社では、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細なイメージを提示しています。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示しています。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。 目次• 1 Executive Summaryo 1.1 Market overview o Exhibit 01: Executive Summary - Chart on Market Overview o Exhibit 02: Executive Summary - Data Table on Market Overview o Exhibit 03: Executive Summary - Chart on Global Market Characteristics o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape o Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user o Exhibit 06: Executive Summary - Chart on Market Segmentation by Type o Exhibit 07: Executive Summary - Chart on Incremental Growth o Exhibit 08: Executive Summary - Data Table on Incremental Growth o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning • 2 Market Landscape o 2.1 Market ecosystem o Exhibit 10: Parent market o Exhibit 11: Market Characteristics • 3 Market Sizing o 3.1 Market definition o Exhibit 12: Offerings of vendors included in the market definition o 3.2 Market segment analysis o Exhibit 13: Market segments o 3.3 Market size 2023 o 3.4 Market outlook: Forecast for 2023-2028 o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion) o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion) o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%) o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%) • 4 Historic Market Size o 4.1 Global migraine drugs market 2018 - 2022 o Exhibit 18: Historic Market Size - Data Table on global migraine drugs market 2018 - 2022 ($ billion) o 4.2 End-user Segment Analysis 2018 - 2022 o Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion) o 4.3 Type Segment Analysis 2018 - 2022 o Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion) o 4.4 Geography Segment Analysis 2018 - 2022 o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion) o 4.5 Country Segment Analysis 2018 - 2022 o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion) • 5 Five Forces Analysis o 5.1 Five forces summary o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028 o 5.2 Bargaining power of buyers o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028 o 5.3 Bargaining power of suppliers o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028 o 5.4 Threat of new entrants o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028 o 5.5 Threat of substitutes o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028 o 5.6 Threat of rivalry o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028 o 5.7 Market condition o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028 • 6 Market Segmentation by End-user o 6.1 Market segments o Exhibit 30: Chart on End-user - Market share 2023-2028 (%) o Exhibit 31: Data Table on End-user - Market share 2023-2028 (%) o 6.2 Comparison by End-user o Exhibit 32: Chart on Comparison by End-user o Exhibit 33: Data Table on Comparison by End-user o 6.3 Hospitals - Market size and forecast 2023-2028 o Exhibit 34: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion) o Exhibit 35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion) o Exhibit 36: Chart on Hospitals - Year-over-year growth 2023-2028 (%) o Exhibit 37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%) o 6.4 Retail - Market size and forecast 2023-2028 o Exhibit 38: Chart on Retail - Market size and forecast 2023-2028 ($ billion) o Exhibit 39: Data Table on Retail - Market size and forecast 2023-2028 ($ billion) o Exhibit 40: Chart on Retail - Year-over-year growth 2023-2028 (%) o Exhibit 41: Data Table on Retail - Year-over-year growth 2023-2028 (%) o 6.5 Online - Market size and forecast 2023-2028 o Exhibit 42: Chart on Online - Market size and forecast 2023-2028 ($ billion) o Exhibit 43: Data Table on Online - Market size and forecast 2023-2028 ($ billion) o Exhibit 44: Chart on Online - Year-over-year growth 2023-2028 (%) o Exhibit 45: Data Table on Online - Year-over-year growth 2023-2028 (%) o 6.6 Market opportunity by End-user o Exhibit 46: Market opportunity by End-user ($ billion) o Exhibit 47: Data Table on Market opportunity by End-user ($ billion) • 7 Market Segmentation by Type o 7.1 Market segments o Exhibit 48: Chart on Type - Market share 2023-2028 (%) o Exhibit 49: Data Table on Type - Market share 2023-2028 (%) o 7.2 Comparison by Type o Exhibit 50: Chart on Comparison by Type o Exhibit 51: Data Table on Comparison by Type o 7.3 Preventive - Market size and forecast 2023-2028 o Exhibit 52: Chart on Preventive - Market size and forecast 2023-2028 ($ billion) o Exhibit 53: Data Table on Preventive - Market size and forecast 2023-2028 ($ billion) o Exhibit 54: Chart on Preventive - Year-over-year growth 2023-2028 (%) o Exhibit 55: Data Table on Preventive - Year-over-year growth 2023-2028 (%) o 7.4 Abortive - Market size and forecast 2023-2028 o Exhibit 56: Chart on Abortive - Market size and forecast 2023-2028 ($ billion) o Exhibit 57: Data Table on Abortive - Market size and forecast 2023-2028 ($ billion) o Exhibit 58: Chart on Abortive - Year-over-year growth 2023-2028 (%) o Exhibit 59: Data Table on Abortive - Year-over-year growth 2023-2028 (%) o 7.5 Market opportunity by Type o Exhibit 60: Market opportunity by Type ($ billion) o Exhibit 61: Data Table on Market opportunity by Type ($ billion) • 8 Customer Landscape o 8.1 Customer landscape overview o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria • 9 Geographic Landscape o 9.1 Geographic segmentation o Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%) o Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%) o 9.2 Geographic comparison o Exhibit 65: Chart on Geographic comparison o Exhibit 66: Data Table on Geographic comparison o 9.3 North America - Market size and forecast 2023-2028 o Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion) o Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion) o Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%) o Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%) o 9.4 Europe - Market size and forecast 2023-2028 o Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion) o Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion) o Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%) o Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%) o 9.5 Asia - Market size and forecast 2023-2028 o Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion) o Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion) o Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%) o Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%) o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028 o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion) o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion) o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%) o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%) o 9.7 US - Market size and forecast 2023-2028 o Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion) o Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion) o Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%) o Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%) o 9.8 Germany - Market size and forecast 2023-2028 o Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion) o Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion) o Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%) o Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%) o 9.9 Canada - Market size and forecast 2023-2028 o Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ billion) o Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ billion) o Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%) o Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%) o 9.10 China - Market size and forecast 2023-2028 o Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion) o Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion) o Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%) o Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%) o 9.11 Japan - Market size and forecast 2023-2028 o Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion) o Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion) o Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%) o Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%) o 9.12 Market opportunity By Geographical Landscape o Exhibit 103: Market opportunity By Geographical Landscape ($ billion) o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion) • 10 Drivers, Challenges, and Trends o 10.1 Market drivers o 10.2 Market challenges o 10.3 Impact of drivers and challenges o Exhibit 105: Impact of drivers and challenges in 2023 and 2028 o 10.4 Market trends • 11 Vendor Landscape o 11.1 Overview o 11.2 Vendor landscape o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation o 11.3 Landscape disruption o Exhibit 107: Overview on factors of disruption o 11.4 Industry risks o Exhibit 108: Impact of key risks on business • 12 Vendor Analysis o 12.1 Vendors covered o Exhibit 109: Vendors covered o 12.2 Market positioning of vendors o Exhibit 110: Matrix on vendor position and classification o 12.3 AbbVie Inc. o Exhibit 111: AbbVie Inc. - Overview o Exhibit 112: AbbVie Inc. - Product / Service o Exhibit 113: AbbVie Inc. - Key news o Exhibit 114: AbbVie Inc. - Key offerings o 12.4 Amgen Inc. o Exhibit 115: Amgen Inc. - Overview o Exhibit 116: Amgen Inc. - Product / Service o Exhibit 117: Amgen Inc. - Key offerings o 12.5 Amneal Pharmaceuticals Inc. o Exhibit 118: Amneal Pharmaceuticals Inc. - Overview o Exhibit 119: Amneal Pharmaceuticals Inc. - Business segments o Exhibit 120: Amneal Pharmaceuticals Inc. - Key news o Exhibit 121: Amneal Pharmaceuticals Inc. - Key offerings o Exhibit 122: Amneal Pharmaceuticals Inc. - Segment focus o 12.6 AstraZeneca Plc o Exhibit 123: AstraZeneca Plc - Overview o Exhibit 124: AstraZeneca Plc - Product / Service o Exhibit 125: AstraZeneca Plc - Key news o Exhibit 126: AstraZeneca Plc - Key offerings o 12.7 Eli Lilly and Co. o Exhibit 127: Eli Lilly and Co. - Overview o Exhibit 128: Eli Lilly and Co. - Product / Service o Exhibit 129: Eli Lilly and Co. - Key news o Exhibit 130: Eli Lilly and Co. - Key offerings o 12.8 Endo International Plc o Exhibit 131: Endo International Plc - Overview o Exhibit 132: Endo International Plc - Business segments o Exhibit 133: Endo International Plc - Key news o Exhibit 134: Endo International Plc - Key offerings o Exhibit 135: Endo International Plc - Segment focus o 12.9 GlaxoSmithKline Plc o Exhibit 136: GlaxoSmithKline Plc - Overview o Exhibit 137: GlaxoSmithKline Plc - Business segments o Exhibit 138: GlaxoSmithKline Plc - Key news o Exhibit 139: GlaxoSmithKline Plc - Key offerings o Exhibit 140: GlaxoSmithKline Plc - Segment focus o 12.10 H Lundbeck AS o Exhibit 141: H Lundbeck AS - Overview o Exhibit 142: H Lundbeck AS - Product / Service o Exhibit 143: H Lundbeck AS - Key offerings o 12.11 Johnson and Johnson o Exhibit 144: Johnson and Johnson - Overview o Exhibit 145: Johnson and Johnson - Business segments o Exhibit 146: Johnson and Johnson - Key news o Exhibit 147: Johnson and Johnson - Key offerings o Exhibit 148: Johnson and Johnson - Segment focus o 12.12 Merck and Co. Inc. o Exhibit 149: Merck and Co. Inc. - Overview o Exhibit 150: Merck and Co. Inc. - Business segments o Exhibit 151: Merck and Co. Inc. - Key news o Exhibit 152: Merck and Co. Inc. - Key offerings o Exhibit 153: Merck and Co. Inc. - Segment focus o 12.13 Novartis AG o Exhibit 154: Novartis AG - Overview o Exhibit 155: Novartis AG - Business segments o Exhibit 156: Novartis AG - Key offerings o Exhibit 157: Novartis AG - Segment focus o 12.14 Otsuka Holdings Co. Ltd. o Exhibit 158: Otsuka Holdings Co. Ltd. - Overview o Exhibit 159: Otsuka Holdings Co. Ltd. - Business segments o Exhibit 160: Otsuka Holdings Co. Ltd. - Key offerings o Exhibit 161: Otsuka Holdings Co. Ltd. - Segment focus o 12.15 Pfizer Inc. o Exhibit 162: Pfizer Inc. - Overview o Exhibit 163: Pfizer Inc. - Product / Service o Exhibit 164: Pfizer Inc. - Key news o Exhibit 165: Pfizer Inc. - Key offerings o 12.16 Sanofi SA o Exhibit 166: Sanofi SA - Overview o Exhibit 167: Sanofi SA - Business segments o Exhibit 168: Sanofi SA - Key news o Exhibit 169: Sanofi SA - Key offerings o Exhibit 170: Sanofi SA - Segment focus o 12.17 Teva Pharmaceutical Industries Ltd. o Exhibit 171: Teva Pharmaceutical Industries Ltd. - Overview o Exhibit 172: Teva Pharmaceutical Industries Ltd. - Business segments o Exhibit 173: Teva Pharmaceutical Industries Ltd. - Key news o Exhibit 174: Teva Pharmaceutical Industries Ltd. - Key offerings o Exhibit 175: Teva Pharmaceutical Industries Ltd. - Segment focus • 13 Appendix o 13.1 Scope of the report o 13.2 Inclusions and exclusions checklist o Exhibit 176: Inclusions checklist o Exhibit 177: Exclusions checklist o 13.3 Currency conversion rates for US$ o Exhibit 178: Currency conversion rates for US$ o 13.4 Research methodology o Exhibit 179: Research methodology o Exhibit 180: Validation techniques employed for market sizing o Exhibit 181: Information sources o 13.5 List of abbreviations o Exhibit 182: List of abbreviations Exhibits: Exhibits1: Executive Summary - Chart on Market Overview Exhibits2: Executive Summary - Data Table on Market Overview Exhibits3: Executive Summary - Chart on Global Market Characteristics Exhibits4: Executive Summary - Chart on Market By Geographical Landscape Exhibits5: Executive Summary - Chart on Market Segmentation by End-user Exhibits6: Executive Summary - Chart on Market Segmentation by Type Exhibits7: Executive Summary - Chart on Incremental Growth Exhibits8: Executive Summary - Data Table on Incremental Growth Exhibits9: Executive Summary - Chart on Vendor Market Positioning Exhibits10: Parent market Exhibits11: Market Characteristics Exhibits12: Offerings of vendors included in the market definition Exhibits13: Market segments Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion) Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion) Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%) Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%) Exhibits18: Historic Market Size - Data Table on global migraine drugs market 2018 - 2022 ($ billion) Exhibits19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion) Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ billion) Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion) Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion) Exhibits23: Five forces analysis - Comparison between 2023 and 2028 Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028 Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028 Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028 Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028 Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028 Exhibits29: Chart on Market condition - Five forces 2023 and 2028 Exhibits30: Chart on End-user - Market share 2023-2028 (%) Exhibits31: Data Table on End-user - Market share 2023-2028 (%) Exhibits32: Chart on Comparison by End-user Exhibits33: Data Table on Comparison by End-user Exhibits34: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion) Exhibits35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion) Exhibits36: Chart on Hospitals - Year-over-year growth 2023-2028 (%) Exhibits37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%) Exhibits38: Chart on Retail - Market size and forecast 2023-2028 ($ billion) Exhibits39: Data Table on Retail - Market size and forecast 2023-2028 ($ billion) Exhibits40: Chart on Retail - Year-over-year growth 2023-2028 (%) Exhibits41: Data Table on Retail - Year-over-year growth 2023-2028 (%) Exhibits42: Chart on Online - Market size and forecast 2023-2028 ($ billion) Exhibits43: Data Table on Online - Market size and forecast 2023-2028 ($ billion) Exhibits44: Chart on Online - Year-over-year growth 2023-2028 (%) Exhibits45: Data Table on Online - Year-over-year growth 2023-2028 (%) Exhibits46: Market opportunity by End-user ($ billion) Exhibits47: Data Table on Market opportunity by End-user ($ billion) Exhibits48: Chart on Type - Market share 2023-2028 (%) Exhibits49: Data Table on Type - Market share 2023-2028 (%) Exhibits50: Chart on Comparison by Type Exhibits51: Data Table on Comparison by Type Exhibits52: Chart on Preventive - Market size and forecast 2023-2028 ($ billion) Exhibits53: Data Table on Preventive - Market size and forecast 2023-2028 ($ billion) Exhibits54: Chart on Preventive - Year-over-year growth 2023-2028 (%) Exhibits55: Data Table on Preventive - Year-over-year growth 2023-2028 (%) Exhibits56: Chart on Abortive - Market size and forecast 2023-2028 ($ billion) Exhibits57: Data Table on Abortive - Market size and forecast 2023-2028 ($ billion) Exhibits58: Chart on Abortive - Year-over-year growth 2023-2028 (%) Exhibits59: Data Table on Abortive - Year-over-year growth 2023-2028 (%) Exhibits60: Market opportunity by Type ($ billion) Exhibits61: Data Table on Market opportunity by Type ($ billion) Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%) Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%) Exhibits65: Chart on Geographic comparison Exhibits66: Data Table on Geographic comparison Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion) Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion) Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%) Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%) Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion) Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion) Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%) Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%) Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ billion) Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion) Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%) Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%) Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion) Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion) Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%) Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%) Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion) Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion) Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%) Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%) Exhibits87: Chart on Germany - Market size and forecast 2023-2028 ($ billion) Exhibits88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion) Exhibits89: Chart on Germany - Year-over-year growth 2023-2028 (%) Exhibits90: Data Table on Germany - Year-over-year growth 2023-2028 (%) Exhibits91: Chart on Canada - Market size and forecast 2023-2028 ($ billion) Exhibits92: Data Table on Canada - Market size and forecast 2023-2028 ($ billion) Exhibits93: Chart on Canada - Year-over-year growth 2023-2028 (%) Exhibits94: Data Table on Canada - Year-over-year growth 2023-2028 (%) Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ billion) Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ billion) Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%) Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%) Exhibits99: Chart on Japan - Market size and forecast 2023-2028 ($ billion) Exhibits100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion) Exhibits101: Chart on Japan - Year-over-year growth 2023-2028 (%) Exhibits102: Data Table on Japan - Year-over-year growth 2023-2028 (%) Exhibits103: Market opportunity By Geographical Landscape ($ billion) Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion) Exhibits105: Impact of drivers and challenges in 2023 and 2028 Exhibits106: Overview on Criticality of inputs and Factors of differentiation Exhibits107: Overview on factors of disruption Exhibits108: Impact of key risks on business Exhibits109: Vendors covered Exhibits110: Matrix on vendor position and classification Exhibits111: AbbVie Inc. - Overview Exhibits112: AbbVie Inc. - Product / Service Exhibits113: AbbVie Inc. - Key news Exhibits114: AbbVie Inc. - Key offerings Exhibits115: Amgen Inc. - Overview Exhibits116: Amgen Inc. - Product / Service Exhibits117: Amgen Inc. - Key offerings Exhibits118: Amneal Pharmaceuticals Inc. - Overview Exhibits119: Amneal Pharmaceuticals Inc. - Business segments Exhibits120: Amneal Pharmaceuticals Inc. - Key news Exhibits121: Amneal Pharmaceuticals Inc. - Key offerings Exhibits122: Amneal Pharmaceuticals Inc. - Segment focus Exhibits123: AstraZeneca Plc - Overview Exhibits124: AstraZeneca Plc - Product / Service Exhibits125: AstraZeneca Plc - Key news Exhibits126: AstraZeneca Plc - Key offerings Exhibits127: Eli Lilly and Co. - Overview Exhibits128: Eli Lilly and Co. - Product / Service Exhibits129: Eli Lilly and Co. - Key news Exhibits130: Eli Lilly and Co. - Key offerings Exhibits131: Endo International Plc - Overview Exhibits132: Endo International Plc - Business segments Exhibits133: Endo International Plc - Key news Exhibits134: Endo International Plc - Key offerings Exhibits135: Endo International Plc - Segment focus Exhibits136: GlaxoSmithKline Plc - Overview Exhibits137: GlaxoSmithKline Plc - Business segments Exhibits138: GlaxoSmithKline Plc - Key news Exhibits139: GlaxoSmithKline Plc - Key offerings Exhibits140: GlaxoSmithKline Plc - Segment focus Exhibits141: H Lundbeck AS - Overview Exhibits142: H Lundbeck AS - Product / Service Exhibits143: H Lundbeck AS - Key offerings Exhibits144: Johnson and Johnson - Overview Exhibits145: Johnson and Johnson - Business segments Exhibits146: Johnson and Johnson - Key news Exhibits147: Johnson and Johnson - Key offerings Exhibits148: Johnson and Johnson - Segment focus Exhibits149: Merck and Co. Inc. - Overview Exhibits150: Merck and Co. Inc. - Business segments Exhibits151: Merck and Co. Inc. - Key news Exhibits152: Merck and Co. Inc. - Key offerings Exhibits153: Merck and Co. Inc. - Segment focus Exhibits154: Novartis AG - Overview Exhibits155: Novartis AG - Business segments Exhibits156: Novartis AG - Key offerings Exhibits157: Novartis AG - Segment focus Exhibits158: Otsuka Holdings Co. Ltd. - Overview Exhibits159: Otsuka Holdings Co. Ltd. - Business segments Exhibits160: Otsuka Holdings Co. Ltd. - Key offerings Exhibits161: Otsuka Holdings Co. Ltd. - Segment focus Exhibits162: Pfizer Inc. - Overview Exhibits163: Pfizer Inc. - Product / Service Exhibits164: Pfizer Inc. - Key news Exhibits165: Pfizer Inc. - Key offerings Exhibits166: Sanofi SA - Overview Exhibits167: Sanofi SA - Business segments Exhibits168: Sanofi SA - Key news Exhibits169: Sanofi SA - Key offerings Exhibits170: Sanofi SA - Segment focus Exhibits171: Teva Pharmaceutical Industries Ltd. - Overview Exhibits172: Teva Pharmaceutical Industries Ltd. - Business segments Exhibits173: Teva Pharmaceutical Industries Ltd. - Key news Exhibits174: Teva Pharmaceutical Industries Ltd. - Key offerings Exhibits175: Teva Pharmaceutical Industries Ltd. - Segment focus Exhibits176: Inclusions checklist Exhibits177: Exclusions checklist Exhibits178: Currency conversion rates for US$ Exhibits179: Research methodology Exhibits180: Validation techniques employed for market sizing Exhibits181: Information sources Exhibits182: List of abbreviations
SummaryGlobal Migraine Drugs Market 2023-2027 Table of Contents• 1 Executive Summaryo 1.1 Market overview o Exhibit 01: Executive Summary - Chart on Market Overview o Exhibit 02: Executive Summary - Data Table on Market Overview o Exhibit 03: Executive Summary - Chart on Global Market Characteristics o Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape o Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user o Exhibit 06: Executive Summary - Chart on Market Segmentation by Type o Exhibit 07: Executive Summary - Chart on Incremental Growth o Exhibit 08: Executive Summary - Data Table on Incremental Growth o Exhibit 09: Executive Summary - Chart on Vendor Market Positioning • 2 Market Landscape o 2.1 Market ecosystem o Exhibit 10: Parent market o Exhibit 11: Market Characteristics • 3 Market Sizing o 3.1 Market definition o Exhibit 12: Offerings of vendors included in the market definition o 3.2 Market segment analysis o Exhibit 13: Market segments o 3.3 Market size 2023 o 3.4 Market outlook: Forecast for 2023-2028 o Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion) o Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion) o Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%) o Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%) • 4 Historic Market Size o 4.1 Global migraine drugs market 2018 - 2022 o Exhibit 18: Historic Market Size - Data Table on global migraine drugs market 2018 - 2022 ($ billion) o 4.2 End-user Segment Analysis 2018 - 2022 o Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion) o 4.3 Type Segment Analysis 2018 - 2022 o Exhibit 20: Historic Market Size - Type Segment 2018 - 2022 ($ billion) o 4.4 Geography Segment Analysis 2018 - 2022 o Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion) o 4.5 Country Segment Analysis 2018 - 2022 o Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion) • 5 Five Forces Analysis o 5.1 Five forces summary o Exhibit 23: Five forces analysis - Comparison between 2023 and 2028 o 5.2 Bargaining power of buyers o Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028 o 5.3 Bargaining power of suppliers o Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028 o 5.4 Threat of new entrants o Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028 o 5.5 Threat of substitutes o Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028 o 5.6 Threat of rivalry o Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028 o 5.7 Market condition o Exhibit 29: Chart on Market condition - Five forces 2023 and 2028 • 6 Market Segmentation by End-user o 6.1 Market segments o Exhibit 30: Chart on End-user - Market share 2023-2028 (%) o Exhibit 31: Data Table on End-user - Market share 2023-2028 (%) o 6.2 Comparison by End-user o Exhibit 32: Chart on Comparison by End-user o Exhibit 33: Data Table on Comparison by End-user o 6.3 Hospitals - Market size and forecast 2023-2028 o Exhibit 34: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion) o Exhibit 35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion) o Exhibit 36: Chart on Hospitals - Year-over-year growth 2023-2028 (%) o Exhibit 37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%) o 6.4 Retail - Market size and forecast 2023-2028 o Exhibit 38: Chart on Retail - Market size and forecast 2023-2028 ($ billion) o Exhibit 39: Data Table on Retail - Market size and forecast 2023-2028 ($ billion) o Exhibit 40: Chart on Retail - Year-over-year growth 2023-2028 (%) o Exhibit 41: Data Table on Retail - Year-over-year growth 2023-2028 (%) o 6.5 Online - Market size and forecast 2023-2028 o Exhibit 42: Chart on Online - Market size and forecast 2023-2028 ($ billion) o Exhibit 43: Data Table on Online - Market size and forecast 2023-2028 ($ billion) o Exhibit 44: Chart on Online - Year-over-year growth 2023-2028 (%) o Exhibit 45: Data Table on Online - Year-over-year growth 2023-2028 (%) o 6.6 Market opportunity by End-user o Exhibit 46: Market opportunity by End-user ($ billion) o Exhibit 47: Data Table on Market opportunity by End-user ($ billion) • 7 Market Segmentation by Type o 7.1 Market segments o Exhibit 48: Chart on Type - Market share 2023-2028 (%) o Exhibit 49: Data Table on Type - Market share 2023-2028 (%) o 7.2 Comparison by Type o Exhibit 50: Chart on Comparison by Type o Exhibit 51: Data Table on Comparison by Type o 7.3 Preventive - Market size and forecast 2023-2028 o Exhibit 52: Chart on Preventive - Market size and forecast 2023-2028 ($ billion) o Exhibit 53: Data Table on Preventive - Market size and forecast 2023-2028 ($ billion) o Exhibit 54: Chart on Preventive - Year-over-year growth 2023-2028 (%) o Exhibit 55: Data Table on Preventive - Year-over-year growth 2023-2028 (%) o 7.4 Abortive - Market size and forecast 2023-2028 o Exhibit 56: Chart on Abortive - Market size and forecast 2023-2028 ($ billion) o Exhibit 57: Data Table on Abortive - Market size and forecast 2023-2028 ($ billion) o Exhibit 58: Chart on Abortive - Year-over-year growth 2023-2028 (%) o Exhibit 59: Data Table on Abortive - Year-over-year growth 2023-2028 (%) o 7.5 Market opportunity by Type o Exhibit 60: Market opportunity by Type ($ billion) o Exhibit 61: Data Table on Market opportunity by Type ($ billion) • 8 Customer Landscape o 8.1 Customer landscape overview o Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria • 9 Geographic Landscape o 9.1 Geographic segmentation o Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%) o Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%) o 9.2 Geographic comparison o Exhibit 65: Chart on Geographic comparison o Exhibit 66: Data Table on Geographic comparison o 9.3 North America - Market size and forecast 2023-2028 o Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion) o Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion) o Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%) o Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%) o 9.4 Europe - Market size and forecast 2023-2028 o Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion) o Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion) o Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%) o Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%) o 9.5 Asia - Market size and forecast 2023-2028 o Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion) o Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion) o Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%) o Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%) o 9.6 Rest of World (ROW) - Market size and forecast 2023-2028 o Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion) o Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion) o Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%) o Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%) o 9.7 US - Market size and forecast 2023-2028 o Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion) o Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion) o Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%) o Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%) o 9.8 Germany - Market size and forecast 2023-2028 o Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion) o Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion) o Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%) o Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%) o 9.9 Canada - Market size and forecast 2023-2028 o Exhibit 91: Chart on Canada - Market size and forecast 2023-2028 ($ billion) o Exhibit 92: Data Table on Canada - Market size and forecast 2023-2028 ($ billion) o Exhibit 93: Chart on Canada - Year-over-year growth 2023-2028 (%) o Exhibit 94: Data Table on Canada - Year-over-year growth 2023-2028 (%) o 9.10 China - Market size and forecast 2023-2028 o Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion) o Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion) o Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%) o Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%) o 9.11 Japan - Market size and forecast 2023-2028 o Exhibit 99: Chart on Japan - Market size and forecast 2023-2028 ($ billion) o Exhibit 100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion) o Exhibit 101: Chart on Japan - Year-over-year growth 2023-2028 (%) o Exhibit 102: Data Table on Japan - Year-over-year growth 2023-2028 (%) o 9.12 Market opportunity By Geographical Landscape o Exhibit 103: Market opportunity By Geographical Landscape ($ billion) o Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion) • 10 Drivers, Challenges, and Trends o 10.1 Market drivers o 10.2 Market challenges o 10.3 Impact of drivers and challenges o Exhibit 105: Impact of drivers and challenges in 2023 and 2028 o 10.4 Market trends • 11 Vendor Landscape o 11.1 Overview o 11.2 Vendor landscape o Exhibit 106: Overview on Criticality of inputs and Factors of differentiation o 11.3 Landscape disruption o Exhibit 107: Overview on factors of disruption o 11.4 Industry risks o Exhibit 108: Impact of key risks on business • 12 Vendor Analysis o 12.1 Vendors covered o Exhibit 109: Vendors covered o 12.2 Market positioning of vendors o Exhibit 110: Matrix on vendor position and classification o 12.3 AbbVie Inc. o Exhibit 111: AbbVie Inc. - Overview o Exhibit 112: AbbVie Inc. - Product / Service o Exhibit 113: AbbVie Inc. - Key news o Exhibit 114: AbbVie Inc. - Key offerings o 12.4 Amgen Inc. o Exhibit 115: Amgen Inc. - Overview o Exhibit 116: Amgen Inc. - Product / Service o Exhibit 117: Amgen Inc. - Key offerings o 12.5 Amneal Pharmaceuticals Inc. o Exhibit 118: Amneal Pharmaceuticals Inc. - Overview o Exhibit 119: Amneal Pharmaceuticals Inc. - Business segments o Exhibit 120: Amneal Pharmaceuticals Inc. - Key news o Exhibit 121: Amneal Pharmaceuticals Inc. - Key offerings o Exhibit 122: Amneal Pharmaceuticals Inc. - Segment focus o 12.6 AstraZeneca Plc o Exhibit 123: AstraZeneca Plc - Overview o Exhibit 124: AstraZeneca Plc - Product / Service o Exhibit 125: AstraZeneca Plc - Key news o Exhibit 126: AstraZeneca Plc - Key offerings o 12.7 Eli Lilly and Co. o Exhibit 127: Eli Lilly and Co. - Overview o Exhibit 128: Eli Lilly and Co. - Product / Service o Exhibit 129: Eli Lilly and Co. - Key news o Exhibit 130: Eli Lilly and Co. - Key offerings o 12.8 Endo International Plc o Exhibit 131: Endo International Plc - Overview o Exhibit 132: Endo International Plc - Business segments o Exhibit 133: Endo International Plc - Key news o Exhibit 134: Endo International Plc - Key offerings o Exhibit 135: Endo International Plc - Segment focus o 12.9 GlaxoSmithKline Plc o Exhibit 136: GlaxoSmithKline Plc - Overview o Exhibit 137: GlaxoSmithKline Plc - Business segments o Exhibit 138: GlaxoSmithKline Plc - Key news o Exhibit 139: GlaxoSmithKline Plc - Key offerings o Exhibit 140: GlaxoSmithKline Plc - Segment focus o 12.10 H Lundbeck AS o Exhibit 141: H Lundbeck AS - Overview o Exhibit 142: H Lundbeck AS - Product / Service o Exhibit 143: H Lundbeck AS - Key offerings o 12.11 Johnson and Johnson o Exhibit 144: Johnson and Johnson - Overview o Exhibit 145: Johnson and Johnson - Business segments o Exhibit 146: Johnson and Johnson - Key news o Exhibit 147: Johnson and Johnson - Key offerings o Exhibit 148: Johnson and Johnson - Segment focus o 12.12 Merck and Co. Inc. o Exhibit 149: Merck and Co. Inc. - Overview o Exhibit 150: Merck and Co. Inc. - Business segments o Exhibit 151: Merck and Co. Inc. - Key news o Exhibit 152: Merck and Co. Inc. - Key offerings o Exhibit 153: Merck and Co. Inc. - Segment focus o 12.13 Novartis AG o Exhibit 154: Novartis AG - Overview o Exhibit 155: Novartis AG - Business segments o Exhibit 156: Novartis AG - Key offerings o Exhibit 157: Novartis AG - Segment focus o 12.14 Otsuka Holdings Co. Ltd. o Exhibit 158: Otsuka Holdings Co. Ltd. - Overview o Exhibit 159: Otsuka Holdings Co. Ltd. - Business segments o Exhibit 160: Otsuka Holdings Co. Ltd. - Key offerings o Exhibit 161: Otsuka Holdings Co. Ltd. - Segment focus o 12.15 Pfizer Inc. o Exhibit 162: Pfizer Inc. - Overview o Exhibit 163: Pfizer Inc. - Product / Service o Exhibit 164: Pfizer Inc. - Key news o Exhibit 165: Pfizer Inc. - Key offerings o 12.16 Sanofi SA o Exhibit 166: Sanofi SA - Overview o Exhibit 167: Sanofi SA - Business segments o Exhibit 168: Sanofi SA - Key news o Exhibit 169: Sanofi SA - Key offerings o Exhibit 170: Sanofi SA - Segment focus o 12.17 Teva Pharmaceutical Industries Ltd. o Exhibit 171: Teva Pharmaceutical Industries Ltd. - Overview o Exhibit 172: Teva Pharmaceutical Industries Ltd. - Business segments o Exhibit 173: Teva Pharmaceutical Industries Ltd. - Key news o Exhibit 174: Teva Pharmaceutical Industries Ltd. - Key offerings o Exhibit 175: Teva Pharmaceutical Industries Ltd. - Segment focus • 13 Appendix o 13.1 Scope of the report o 13.2 Inclusions and exclusions checklist o Exhibit 176: Inclusions checklist o Exhibit 177: Exclusions checklist o 13.3 Currency conversion rates for US$ o Exhibit 178: Currency conversion rates for US$ o 13.4 Research methodology o Exhibit 179: Research methodology o Exhibit 180: Validation techniques employed for market sizing o Exhibit 181: Information sources o 13.5 List of abbreviations o Exhibit 182: List of abbreviations Exhibits: Exhibits1: Executive Summary - Chart on Market Overview Exhibits2: Executive Summary - Data Table on Market Overview Exhibits3: Executive Summary - Chart on Global Market Characteristics Exhibits4: Executive Summary - Chart on Market By Geographical Landscape Exhibits5: Executive Summary - Chart on Market Segmentation by End-user Exhibits6: Executive Summary - Chart on Market Segmentation by Type Exhibits7: Executive Summary - Chart on Incremental Growth Exhibits8: Executive Summary - Data Table on Incremental Growth Exhibits9: Executive Summary - Chart on Vendor Market Positioning Exhibits10: Parent market Exhibits11: Market Characteristics Exhibits12: Offerings of vendors included in the market definition Exhibits13: Market segments Exhibits14: Chart on Global - Market size and forecast 2023-2028 ($ billion) Exhibits15: Data Table on Global - Market size and forecast 2023-2028 ($ billion) Exhibits16: Chart on Global Market: Year-over-year growth 2023-2028 (%) Exhibits17: Data Table on Global Market: Year-over-year growth 2023-2028 (%) Exhibits18: Historic Market Size - Data Table on global migraine drugs market 2018 - 2022 ($ billion) Exhibits19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion) Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ billion) Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion) Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ billion) Exhibits23: Five forces analysis - Comparison between 2023 and 2028 Exhibits24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028 Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028 Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028 Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028 Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028 Exhibits29: Chart on Market condition - Five forces 2023 and 2028 Exhibits30: Chart on End-user - Market share 2023-2028 (%) Exhibits31: Data Table on End-user - Market share 2023-2028 (%) Exhibits32: Chart on Comparison by End-user Exhibits33: Data Table on Comparison by End-user Exhibits34: Chart on Hospitals - Market size and forecast 2023-2028 ($ billion) Exhibits35: Data Table on Hospitals - Market size and forecast 2023-2028 ($ billion) Exhibits36: Chart on Hospitals - Year-over-year growth 2023-2028 (%) Exhibits37: Data Table on Hospitals - Year-over-year growth 2023-2028 (%) Exhibits38: Chart on Retail - Market size and forecast 2023-2028 ($ billion) Exhibits39: Data Table on Retail - Market size and forecast 2023-2028 ($ billion) Exhibits40: Chart on Retail - Year-over-year growth 2023-2028 (%) Exhibits41: Data Table on Retail - Year-over-year growth 2023-2028 (%) Exhibits42: Chart on Online - Market size and forecast 2023-2028 ($ billion) Exhibits43: Data Table on Online - Market size and forecast 2023-2028 ($ billion) Exhibits44: Chart on Online - Year-over-year growth 2023-2028 (%) Exhibits45: Data Table on Online - Year-over-year growth 2023-2028 (%) Exhibits46: Market opportunity by End-user ($ billion) Exhibits47: Data Table on Market opportunity by End-user ($ billion) Exhibits48: Chart on Type - Market share 2023-2028 (%) Exhibits49: Data Table on Type - Market share 2023-2028 (%) Exhibits50: Chart on Comparison by Type Exhibits51: Data Table on Comparison by Type Exhibits52: Chart on Preventive - Market size and forecast 2023-2028 ($ billion) Exhibits53: Data Table on Preventive - Market size and forecast 2023-2028 ($ billion) Exhibits54: Chart on Preventive - Year-over-year growth 2023-2028 (%) Exhibits55: Data Table on Preventive - Year-over-year growth 2023-2028 (%) Exhibits56: Chart on Abortive - Market size and forecast 2023-2028 ($ billion) Exhibits57: Data Table on Abortive - Market size and forecast 2023-2028 ($ billion) Exhibits58: Chart on Abortive - Year-over-year growth 2023-2028 (%) Exhibits59: Data Table on Abortive - Year-over-year growth 2023-2028 (%) Exhibits60: Market opportunity by Type ($ billion) Exhibits61: Data Table on Market opportunity by Type ($ billion) Exhibits62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria Exhibits63: Chart on Market share By Geographical Landscape 2023-2028 (%) Exhibits64: Data Table on Market share By Geographical Landscape 2023-2028 (%) Exhibits65: Chart on Geographic comparison Exhibits66: Data Table on Geographic comparison Exhibits67: Chart on North America - Market size and forecast 2023-2028 ($ billion) Exhibits68: Data Table on North America - Market size and forecast 2023-2028 ($ billion) Exhibits69: Chart on North America - Year-over-year growth 2023-2028 (%) Exhibits70: Data Table on North America - Year-over-year growth 2023-2028 (%) Exhibits71: Chart on Europe - Market size and forecast 2023-2028 ($ billion) Exhibits72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion) Exhibits73: Chart on Europe - Year-over-year growth 2023-2028 (%) Exhibits74: Data Table on Europe - Year-over-year growth 2023-2028 (%) Exhibits75: Chart on Asia - Market size and forecast 2023-2028 ($ billion) Exhibits76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion) Exhibits77: Chart on Asia - Year-over-year growth 2023-2028 (%) Exhibits78: Data Table on Asia - Year-over-year growth 2023-2028 (%) Exhibits79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion) Exhibits80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion) Exhibits81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%) Exhibits82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%) Exhibits83: Chart on US - Market size and forecast 2023-2028 ($ billion) Exhibits84: Data Table on US - Market size and forecast 2023-2028 ($ billion) Exhibits85: Chart on US - Year-over-year growth 2023-2028 (%) Exhibits86: Data Table on US - Year-over-year growth 2023-2028 (%) Exhibits87: Chart on Germany - Market size and forecast 2023-2028 ($ billion) Exhibits88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion) Exhibits89: Chart on Germany - Year-over-year growth 2023-2028 (%) Exhibits90: Data Table on Germany - Year-over-year growth 2023-2028 (%) Exhibits91: Chart on Canada - Market size and forecast 2023-2028 ($ billion) Exhibits92: Data Table on Canada - Market size and forecast 2023-2028 ($ billion) Exhibits93: Chart on Canada - Year-over-year growth 2023-2028 (%) Exhibits94: Data Table on Canada - Year-over-year growth 2023-2028 (%) Exhibits95: Chart on China - Market size and forecast 2023-2028 ($ billion) Exhibits96: Data Table on China - Market size and forecast 2023-2028 ($ billion) Exhibits97: Chart on China - Year-over-year growth 2023-2028 (%) Exhibits98: Data Table on China - Year-over-year growth 2023-2028 (%) Exhibits99: Chart on Japan - Market size and forecast 2023-2028 ($ billion) Exhibits100: Data Table on Japan - Market size and forecast 2023-2028 ($ billion) Exhibits101: Chart on Japan - Year-over-year growth 2023-2028 (%) Exhibits102: Data Table on Japan - Year-over-year growth 2023-2028 (%) Exhibits103: Market opportunity By Geographical Landscape ($ billion) Exhibits104: Data Tables on Market opportunity By Geographical Landscape ($ billion) Exhibits105: Impact of drivers and challenges in 2023 and 2028 Exhibits106: Overview on Criticality of inputs and Factors of differentiation Exhibits107: Overview on factors of disruption Exhibits108: Impact of key risks on business Exhibits109: Vendors covered Exhibits110: Matrix on vendor position and classification Exhibits111: AbbVie Inc. - Overview Exhibits112: AbbVie Inc. - Product / Service Exhibits113: AbbVie Inc. - Key news Exhibits114: AbbVie Inc. - Key offerings Exhibits115: Amgen Inc. - Overview Exhibits116: Amgen Inc. - Product / Service Exhibits117: Amgen Inc. - Key offerings Exhibits118: Amneal Pharmaceuticals Inc. - Overview Exhibits119: Amneal Pharmaceuticals Inc. - Business segments Exhibits120: Amneal Pharmaceuticals Inc. - Key news Exhibits121: Amneal Pharmaceuticals Inc. - Key offerings Exhibits122: Amneal Pharmaceuticals Inc. - Segment focus Exhibits123: AstraZeneca Plc - Overview Exhibits124: AstraZeneca Plc - Product / Service Exhibits125: AstraZeneca Plc - Key news Exhibits126: AstraZeneca Plc - Key offerings Exhibits127: Eli Lilly and Co. - Overview Exhibits128: Eli Lilly and Co. - Product / Service Exhibits129: Eli Lilly and Co. - Key news Exhibits130: Eli Lilly and Co. - Key offerings Exhibits131: Endo International Plc - Overview Exhibits132: Endo International Plc - Business segments Exhibits133: Endo International Plc - Key news Exhibits134: Endo International Plc - Key offerings Exhibits135: Endo International Plc - Segment focus Exhibits136: GlaxoSmithKline Plc - Overview Exhibits137: GlaxoSmithKline Plc - Business segments Exhibits138: GlaxoSmithKline Plc - Key news Exhibits139: GlaxoSmithKline Plc - Key offerings Exhibits140: GlaxoSmithKline Plc - Segment focus Exhibits141: H Lundbeck AS - Overview Exhibits142: H Lundbeck AS - Product / Service Exhibits143: H Lundbeck AS - Key offerings Exhibits144: Johnson and Johnson - Overview Exhibits145: Johnson and Johnson - Business segments Exhibits146: Johnson and Johnson - Key news Exhibits147: Johnson and Johnson - Key offerings Exhibits148: Johnson and Johnson - Segment focus Exhibits149: Merck and Co. Inc. - Overview Exhibits150: Merck and Co. Inc. - Business segments Exhibits151: Merck and Co. Inc. - Key news Exhibits152: Merck and Co. Inc. - Key offerings Exhibits153: Merck and Co. Inc. - Segment focus Exhibits154: Novartis AG - Overview Exhibits155: Novartis AG - Business segments Exhibits156: Novartis AG - Key offerings Exhibits157: Novartis AG - Segment focus Exhibits158: Otsuka Holdings Co. Ltd. - Overview Exhibits159: Otsuka Holdings Co. Ltd. - Business segments Exhibits160: Otsuka Holdings Co. Ltd. - Key offerings Exhibits161: Otsuka Holdings Co. Ltd. - Segment focus Exhibits162: Pfizer Inc. - Overview Exhibits163: Pfizer Inc. - Product / Service Exhibits164: Pfizer Inc. - Key news Exhibits165: Pfizer Inc. - Key offerings Exhibits166: Sanofi SA - Overview Exhibits167: Sanofi SA - Business segments Exhibits168: Sanofi SA - Key news Exhibits169: Sanofi SA - Key offerings Exhibits170: Sanofi SA - Segment focus Exhibits171: Teva Pharmaceutical Industries Ltd. - Overview Exhibits172: Teva Pharmaceutical Industries Ltd. - Business segments Exhibits173: Teva Pharmaceutical Industries Ltd. - Key news Exhibits174: Teva Pharmaceutical Industries Ltd. - Key offerings Exhibits175: Teva Pharmaceutical Industries Ltd. - Segment focus Exhibits176: Inclusions checklist Exhibits177: Exclusions checklist Exhibits178: Currency conversion rates for US$ Exhibits179: Research methodology Exhibits180: Validation techniques employed for market sizing Exhibits181: Information sources Exhibits182: List of abbreviations
ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。本レポートと同分野(その他)の最新刊レポートTechNavio 社の最新刊レポート本レポートと同じKEY WORD(migraine)の最新刊レポートよくあるご質問TechNavio社はどのような調査会社ですか?テクナビオ(TechNavio)は英国ロンドンに本社をおく幅広い市場を調査対象とする調査会社インフィニティリサーチ社(Infiniti Research)の調査レポート出版部門です。データリソースはT... もっと見る 調査レポートの納品までの日数はどの程度ですか?在庫のあるものは速納となりますが、平均的には 3-4日と見て下さい。
注文の手続きはどのようになっていますか?1)お客様からの御問い合わせをいただきます。
お支払方法の方法はどのようになっていますか?納品と同時にデータリソース社よりお客様へ請求書(必要に応じて納品書も)を発送いたします。
データリソース社はどのような会社ですか?当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
|
詳細検索
2024/11/08 10:26 154.13 円 166.76 円 202.76 円 |